https://www.complianceacuity.com/final-draft-of-new-iso-13485-medical-devices-quality-management-system-standard-published/2021-07-22T14:12:23-06:00https://www.complianceacuity.com/fda-draft-guidance-for-animal-studies-of-medical-devices/2021-07-22T14:11:57-06:00https://www.complianceacuity.com/status-of-revisions-to-the-european-medical-devices-directive/2021-07-22T14:11:22-06:00https://www.complianceacuity.com/fda-updates-guidance-for-its-510k-refuse-to-accept-policy/2021-07-22T14:10:52-06:00https://www.complianceacuity.com/fda-draft-guidance-distinguishing-device-recalls-from-enhancements/2021-07-22T14:10:17-06:00https://www.complianceacuity.com/fda-announces-availability-of-e-submission-process-for-requesting-cdrh-export-certificates/2021-07-22T14:09:50-06:00https://www.complianceacuity.com/health-canada-intends-to-adopt-ghtf-summary-technical-documentation-sted-format-for-class-iii-and-iv-device-applications/2021-07-22T13:59:13-06:00https://www.complianceacuity.com/notable-archive-complianceacuity-complaint-handling-solution-featured-by-f-d-c-reports/2021-07-22T14:07:30-06:00https://www.complianceacuity.com/health-canada-requests-electronic-filing-of-some-device-license-applications/2021-07-22T14:00:48-06:00https://www.complianceacuity.com/fda-releases-its-final-guidance-document-on-statistical-aspects-of-the-design-and-analysis-of-clinical-trials-for-medical-devices-that-use-bayesian-statistics/2021-07-22T14:01:14-06:00https://www.complianceacuity.com/health-canada-backlogged-in-processing-of-device-license-applications/2021-07-22T14:01:44-06:00https://www.complianceacuity.com/health-canada-decides-to-delay-full-sted-implementation-until-july-1-2011-for-non-in-vitro-diagnostic-class-iii-and-iv-medical-devices/2021-07-22T14:02:10-06:00https://www.complianceacuity.com/industry-has-until-october-4th-to-comment-on-fdas-510k-recommendations-released-july-30th/2021-07-22T14:02:34-06:00https://www.complianceacuity.com/health-canada-gaining-ground-but-still-backlogged-in-device-license-application-processing/2021-07-22T14:03:11-06:00https://www.complianceacuity.com/health-canada-authorizes-e-labeling-for-certain-medical-devices-not-sold-to-the-general-public/2021-07-22T14:03:41-06:00https://www.complianceacuity.com/fda-to-implement-or-reach-a-major-milestone-this-year-2011-for-forty-two-of-its-prior-fifty-five-510k-process-recommendations/2021-07-22T14:04:36-06:00https://www.complianceacuity.com/wondering-how-fdas-udi-rule-might-affect-labelers-heres-a-non-exhaustive-summary/2021-07-22T14:05:19-06:00https://www.complianceacuity.com/fda-announces-significant-changes-to-device-registration-and-listing-system/2021-07-22T14:05:48-06:00https://www.complianceacuity.com/fda-publishes-a-revised-udi-proposed-rule/2021-07-22T14:06:12-06:00https://www.complianceacuity.com/cdrh-accepts-web-based-applications-for-certificates-to-foreign-government/2021-07-22T14:08:21-06:00https://www.complianceacuity.com/fda-announces-public-private-partnership-to-develop-regulatory-science-and-speed-access-to-new-device-technologies/2021-07-22T14:08:53-06:00https://www.complianceacuity.com/has-fda-recently-rejected-your-medical-device-submission-e-copy/2021-07-22T14:09:20-06:00https://www.complianceacuity.com/iso-134852016-deadline-nearly-upon-us/2021-07-22T14:13:18-06:00https://www.complianceacuity.com/new-european-medical-device-regulation-2017-745-date-of-application-26-may-2020-looming-large/2021-07-22T14:14:09-06:00https://www.complianceacuity.com/fda-iso-13485-design-outputs/2021-07-12T16:53:44-06:00https://www.complianceacuity.com/fda-iso-dmr-mdf-design-output/2021-07-22T14:15:45-06:00https://www.complianceacuity.com/iso-14971-probability-of-occurrence-of-harm/2021-07-22T14:19:58-06:00https://www.complianceacuity.com/eu-mdr-ce-marking-on-advertising-materials/2021-07-22T14:19:30-06:00https://www.complianceacuity.com/eu-mdr-applicability-for-changes-to-pre-26-may-2021-devices/2021-07-22T14:18:25-06:00https://www.complianceacuity.com/eu-mdr-changes-to-mdd-installed-devices/2021-07-22T14:17:22-06:00https://www.complianceacuity.com/eu-mdr-mdd-redundant-certification/2021-07-22T14:17:52-06:00https://www.complianceacuity.com/iso-14971-estimating-probability-of-occurrence-of-harm/2021-07-22T14:21:00-06:00https://www.complianceacuity.com/eu-mdr-scope-and-applicability-of-gspr-10-4-1/2021-07-22T14:20:31-06:00https://www.complianceacuity.com/showing-conformity-to-standards/2021-07-22T14:21:27-06:00https://www.complianceacuity.com/risks-from-an-inadequate-development-process-for-software/2021-07-22T14:22:30-06:00https://www.complianceacuity.com/iso-13485-qms-planning-vs-quality-plans/2021-07-22T14:22:58-06:00https://www.complianceacuity.com/fda-remote-regulatory-assessment/2021-07-22T14:21:56-06:00https://www.complianceacuity.com/health-canada-medical-device-importer-requirements-for-dtc-sales/2021-07-22T14:18:57-06:00https://www.complianceacuity.com/health-canada-cmdr-updates-2021/2021-07-22T14:16:44-06:00https://www.complianceacuity.com/eu-mdr-changes-to-mdd-doc-under-eu-mdr-article-120/2021-07-22T14:23:28-06:00https://www.complianceacuity.com/eu-mdr-strategy-for-configurable-software/2021-07-22T14:23:53-06:00https://www.complianceacuity.com/5127-2/2021-07-22T13:57:31-06:00https://www.complianceacuity.com/eu-mdr-pmcf-to-waive-or-not-to-waive/2021-07-31T09:30:37-06:00https://www.complianceacuity.com/fda-mdufma-small-business-determination-sbd-at-the-pre-revenue-stage/2021-07-30T18:00:09-06:00https://www.complianceacuity.com/fdas-21-cfr-%c2%a7820-72-metrology-requirements-vs-test-method-process-validation/2023-04-05T14:34:25-06:00https://www.complianceacuity.com/can-a-customer-survey-be-used-as-part-of-pmcf/2023-04-05T14:48:08-06:00https://www.complianceacuity.com/dont-confuse-fda-part-11-with-fdas-software-validation-requirements-of-%c2%a7820-70i/2023-04-06T10:01:37-06:00https://www.complianceacuity.com/is-that-eqms-platform-such-as-sharepoint-fit-for-its-purpose/2023-04-06T10:14:18-06:00https://www.complianceacuity.com/eifu-mdd-eu-mdr-notified-body-is-required-as-applicable/2023-04-06T10:28:52-06:00https://www.complianceacuity.com/eu-mdd-and-mdr-afap/2023-04-06T11:12:28-06:00https://www.complianceacuity.com/can-the-eu-mdr-pms-procedure-and-pms-plan-be-the-same-thing/2023-04-06T11:37:50-06:00https://www.complianceacuity.com/can-the-eu-mdr-pms-procedure-and-pms-plan-be-the-same-thing-2/2023-04-06T11:35:46-06:00https://www.complianceacuity.com/dont-claim-device-mr-compatibility-until-youve-earned-it/2023-04-06T11:47:56-06:00https://www.complianceacuity.com/fda-510k-aggregate-change-analysis-for-special-510k-cleared-devices/2023-04-06T11:58:06-06:00https://www.complianceacuity.com/health-canada-medical-device-system-license-components-sold-separately/2023-04-06T12:41:31-06:00https://www.complianceacuity.com/fda-medical-device-repackagers-and-relabelers-a-regulatory-overview/2023-04-06T13:00:39-06:00https://www.complianceacuity.com/so-many-adverse-event-reporting-terms-in-various-jurisdictions/2023-04-06T13:10:45-06:00https://www.complianceacuity.com/fda-pma-stakeholder-logistics-strategy/2023-04-06T13:36:29-06:00https://www.complianceacuity.com/eu-mdr-article-22-statement-vs-article-19-declaration/2023-04-06T13:42:07-06:00https://www.complianceacuity.com/regulatory-review-of-marketing-literature-and-other-dhf-elements/2023-04-06T13:53:55-06:00https://www.complianceacuity.com/chatgpt-for-regulatory-documentation/2023-04-06T14:01:35-06:00https://www.complianceacuity.com/eu-mdr-who-must-hold-the-annex-xi-part-a-certificate/2023-04-06T14:15:20-06:00https://www.complianceacuity.com/iso-13485-design-development-obligations-of-contract-manufacturers/2023-04-06T14:22:35-06:00https://www.complianceacuity.com/eu-mdr-transitional-extension-regulation-eu-2023-607-and-expired-mdd-aimdd-certificates/2023-04-06T15:08:41-06:00https://www.complianceacuity.com/eu-mdr-basic-udi-di-essential-design-and-manufacturing-characteristics/2023-04-07T08:02:06-06:00https://www.complianceacuity.com/regulatory-misconduct-allegations/2023-04-07T08:32:41-06:00https://www.complianceacuity.com/eu-ivdr-accessory-definition-triggered-for-an-optional-item/2023-04-07T08:42:32-06:00https://www.complianceacuity.com/biological-evaluation-for-reusable-devices-shelf-life-vs-expected-life/2023-04-07T08:50:57-06:00https://www.complianceacuity.com/problem-containment-actions-for-controlling-regulatory-impact/2023-04-07T09:02:19-06:00https://www.complianceacuity.com/nonconforming-expiration-date/2023-04-07T09:07:00-06:00https://www.complianceacuity.com/eu-mdr-classification-of-accessories/2023-04-07T09:19:23-06:00https://www.complianceacuity.com/eu-mdr-classification-of-accessories-2/2023-04-07T09:29:23-06:00https://www.complianceacuity.com/eu-mdr-notified-body-demanding-use-of-harmonized-standards/2023-04-07T10:36:34-06:00https://www.complianceacuity.com/standards-arent-required-but-are-recommended-to-show-european-conformity/2023-04-07T10:13:21-06:00https://www.complianceacuity.com/help-with-fda-esg-digital-certificates/2023-04-10T09:01:54-06:00https://www.complianceacuity.com/can-multiple-different-devices-be-on-a-single-eu-mdd-mdr-doc/2023-04-10T10:07:29-06:00https://www.complianceacuity.com/fda-medical-device-distributor-private-label-distributor-and-label-overview/2023-04-10T11:06:23-06:00https://www.complianceacuity.com/shelf-life-isnt-always-required-on-medical-device-labels/2023-04-10T11:23:28-06:00https://www.complianceacuity.com/human-factors-data-from-animal-studies/2023-04-10T11:35:00-06:00https://www.complianceacuity.com/quality-agreements-ownership-and-format/2023-04-10T11:46:31-06:00https://www.complianceacuity.com/dhf-documentation-of-design-changes/2023-04-10T11:51:30-06:00https://www.complianceacuity.com/health-canada-licence-amendment-vs-new-licence-application/2023-04-10T11:57:48-06:00https://www.complianceacuity.com/fda-udi-for-class-1-510k-exempt-devices/2023-04-10T12:14:25-06:00https://www.complianceacuity.com/that-advisory-notice-might-be-a-recall/2023-04-11T12:24:39-06:00https://www.complianceacuity.com/recall-initiation-in-the-u-s/2023-04-11T12:18:27-06:00https://www.complianceacuity.com/fda-21-cfr-part-7-vs-part-806-whats-the-difference/2023-04-11T12:37:23-06:00https://www.complianceacuity.com/fda-21-cfr-part-7-vs-part-806-whats-the-difference-2/2023-04-11T12:35:14-06:00https://www.complianceacuity.com/eu-mdr-eudamed-accuracy-monitoring-article-315/2023-04-11T12:43:02-06:00https://www.complianceacuity.com/fda-510k-modifications-inclusion-of-non-triggering-change-details/2023-04-11T12:50:24-06:00https://www.complianceacuity.com/intended-use-vs-indications-for-use-in-fda-submissions-and-the-qms/2023-04-11T17:30:10-06:00https://www.complianceacuity.com/intended-use-vs-indications-for-use-whats-the-difference/2023-04-11T17:35:26-06:00https://www.complianceacuity.com/regulatory-is-part-of-the-design-and-design-team-part-1/2023-04-11T17:47:24-06:00https://www.complianceacuity.com/regulatory-is-part-of-the-design-and-design-team-part-2/2023-04-11T17:59:41-06:00https://www.complianceacuity.com/clearly-identify-design-team-members-contributors-in-the-design-plan/2023-04-11T18:07:33-06:00https://www.complianceacuity.com/udi-for-ivd-devices-used-in-house/2023-04-13T17:50:05-06:00https://www.complianceacuity.com/fda-510k-change-strategy-reprocessing-focused/2023-04-12T11:42:22-06:00https://www.complianceacuity.com/fda-510k-change-strategy-reprocessing-focused-2/2023-04-12T11:45:07-06:00https://www.complianceacuity.com/eu-mdr-pmcf-plan-is-needed-for-legacy-devices/2023-04-12T11:56:37-06:00https://www.complianceacuity.com/udi-for-ivd-devices-used-in-house-2/2023-04-13T17:49:36-06:00https://www.complianceacuity.com/use-of-off-label-clinical-data-in-premarket-submissions/2023-04-13T11:30:32-06:00https://www.complianceacuity.com/udi-for-ivd-devices-used-in-house-part-3/2023-04-14T07:59:41-06:00https://www.complianceacuity.com/eu-mdr-device-lifetime-vs-shelf-life/2023-04-13T19:26:09-06:00https://www.complianceacuity.com/health-canada-class-iv-device-licence-amendments/2023-04-14T08:18:05-06:00https://www.complianceacuity.com/what-changes-are-allowed-for-eu-mdr-article-120-legacy-devices/2023-04-14T08:29:50-06:00https://www.complianceacuity.com/what-if-i-add-an-expiration-date-for-risk-reduction/2023-04-14T08:39:11-06:00https://www.complianceacuity.com/real-time-or-accelerated-aging/2023-04-14T08:53:55-06:00https://www.complianceacuity.com/eu-mdr-clinical-evaluation-report-cer-frequency/2023-04-14T08:59:52-06:00https://www.complianceacuity.com/eu-mdr-accessories-identification-in-the-ifu/2023-04-15T09:16:34-06:00https://www.complianceacuity.com/design-development-includes-regulatory-submissions/2023-04-18T13:53:23-06:00https://www.complianceacuity.com/recall-classification-eu-mdr-ivdr/2023-04-19T10:14:54-06:00https://www.complianceacuity.com/recall-classification-u-s-fda/2023-04-19T10:59:35-06:00https://www.complianceacuity.com/eu-mdr-ivdr-annex-ix-full-qms-vs-annex-xi-production-quality-assurance/2023-04-20T13:37:18-06:00https://www.complianceacuity.com/declarations-of-conformity-u-s-fda-vs-europe/2023-04-21T09:21:09-06:00https://www.complianceacuity.com/external-documents-kept-on-an-externally-controlled-server/2023-04-21T09:43:54-06:00https://www.complianceacuity.com/marketing-for-off-label-use/2023-04-21T10:35:50-06:00https://www.complianceacuity.com/changing-foreign-510k-ownership-to-domestic-subsidiary/2023-04-21T11:02:18-06:00https://www.complianceacuity.com/declaration-of-conformity-vs-certification-of-conformity/2023-04-24T10:06:11-06:00https://www.complianceacuity.com/eu-eifu-regulation-broader-than-many-think/2023-04-24T13:14:18-06:00https://www.complianceacuity.com/fdas-qmsr-final-rule-issued/2024-01-31T11:18:08-06:00https://www.complianceacuity.com/eu-mdr-virtual-importers/2024-01-31T11:59:53-06:00https://www.complianceacuity.com/uk-and-eu-end-users-are-not-importers/2024-01-31T12:07:46-06:00https://www.complianceacuity.com/are-doc-updates-required-for-software-version-changes/2024-01-31T12:13:52-06:00https://www.complianceacuity.com/notifying-your-european-notified-body-about-non-significant-changes/2024-01-31T12:21:59-06:00https://www.complianceacuity.com/u-s-fda-510k-clinical-data-requirements/2024-01-31T12:35:05-06:00https://www.complianceacuity.com/difficulty-submitting-part-806-report-via-fdas-esg-gateway/2024-01-31T13:00:30-06:00https://www.complianceacuity.com/fda-u-s-agent-services/2024-01-31T13:05:59-06:00https://www.complianceacuity.com/responding-to-a-form-fda-483/2024-01-31T13:20:11-06:00https://www.complianceacuity.com/fda-483-responses-how-to-avoid-a-warning-letter/2025-01-06T14:01:59-06:00https://www.complianceacuity.com/fda-qmsr-are-you-ready/2026-01-22T10:57:10-06:00https://www.complianceacuity.com/mdsap-qms-internal-auditing-must-verify-regulatory-compliance/2026-01-22T11:20:30-06:00